APA (7th ed.) Citation

T, L., R, K., AH, E., B, G., K, M., R, R., . . . JK, L. (2023). Polygenic Pharmacogenomic Markers as Predictors of Toxicity Phenotypes in the Treatment of Acute Lymphoblastic Leukemia: A Single-Center Study. JCO precision oncology, 7, e2200580. https://doi.org/10.1200/PO.22.00580

Chicago Style (17th ed.) Citation

T, Larkin, et al. "Polygenic Pharmacogenomic Markers as Predictors of Toxicity Phenotypes in the Treatment of Acute Lymphoblastic Leukemia: A Single-Center Study." JCO Precision Oncology 7 (2023): e2200580. https://doi.org/10.1200/PO.22.00580.

MLA (9th ed.) Citation

T, Larkin, et al. "Polygenic Pharmacogenomic Markers as Predictors of Toxicity Phenotypes in the Treatment of Acute Lymphoblastic Leukemia: A Single-Center Study." JCO Precision Oncology, vol. 7, 2023, p. e2200580, https://doi.org/10.1200/PO.22.00580.